ExodusPoint Capital Management, LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2022$519,000
-7.2%
396,362
+24.7%
0.01%
+16.7%
Q4 2021$559,000
-46.6%
317,800
-34.2%
0.01%
-57.1%
Q3 2021$1,047,000
+705.4%
482,663
+1202.2%
0.01%
+1300.0%
Q2 2021$130,000
-0.8%
37,064
+206.0%
0.00%0.0%
Q4 2020$131,000
-39.6%
12,112
+16.6%
0.00%
-83.3%
Q2 2020$217,00010,3840.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders